Title
Synthesizing Hope: Matter, Knowledge, and Place in South African Drug Discovery,New
Processing time: 1-3 days
US Orders Ships in: 3-5 days
International Orders Ships in: 8-12 days
Return Policy: 15-days return on defective items
Payment Option
Synthesizing Hope opens up the material and social world of pharmaceuticals by focusing on an unexpected place: iThemba Pharmaceuticals. Founded in 2009 with a name taken from the Zulu word for hope, the small South African startup with an elite international scientific board was tasked with drug discovery for tuberculosis, HIV, and malaria. Anne Pollock uses this company as an entry point for exploring how the location of scientific knowledge production matters, not only for the raw materials, manufacture, licensing, and distribution of pharmaceuticals but also for the making of basic scientific knowledge.Consideration of this case exposes the limitations of global health frameworks that implicitly posit rich countries as the only sites of knowledge production. Analysis of iThemba identifies the problems inherent in global north/south divides at the same time as it highlights what is at stake in who makes knowledge and where. It also provides a concrete example for consideration of the contexts and practices of postcolonial science, its constraints, and its promise.Synthesizing Hope explores the many legacies that create conditions of possibility for South African drug discovery, especially the specific form of settler colonialism characterized by apartheid and resource extraction. Paying attention to the infrastructures and laboratory processes of drug discovery underscores the materiality of pharmaceuticals from the perspective of their makers, and tracing the intellectual and material infrastructures of South African drug discovery contributes new insights about larger social, political, and economic orders.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.
- Q: What is the page count of 'Synthesizing Hope'? A: The book contains two hundred eight pages. This length provides a thorough exploration of drug discovery in South Africa.
- Q: What is the binding type of this book? A: This book is available in paperback binding. Paperback is lightweight and flexible, making it easy to carry.
- Q: What are the dimensions of 'Synthesizing Hope'? A: The book measures six inches in length, zero point eight inches in width, and nine point zero two inches in height. These dimensions make it a convenient size for reading.
- Q: Who is the author of 'Synthesizing Hope'? A: The author is Anne Pollock. She provides unique insights into the pharmaceutical industry and postcolonial science.
- Q: What is the main focus of 'Synthesizing Hope'? A: The book focuses on drug discovery in South Africa, particularly at iThemba Pharmaceuticals. It explores how location affects scientific knowledge production.
- Q: Is 'Synthesizing Hope' suitable for academic research? A: Yes, this book is suitable for academic research. It addresses important themes in global health and postcolonial science.
- Q: How does 'Synthesizing Hope' address global health frameworks? A: The book critiques global health frameworks that overlook knowledge production in developing countries. It emphasizes the importance of local contexts in drug discovery.
- Q: What themes are explored in 'Synthesizing Hope'? A: The book explores themes like settler colonialism, scientific knowledge production, and the socio-political implications of drug discovery. These themes highlight the complexities of global health.
- Q: Can 'Synthesizing Hope' be used in university courses? A: Yes, it can be used in university courses. The book provides valuable insights for students studying public health, sociology, and pharmaceutical sciences.
- Q: What is the primary category of 'Synthesizing Hope'? A: The primary category is Infrastructure. The book discusses the infrastructure involved in drug discovery and its implications.
- Q: Does 'Synthesizing Hope' discuss the history of South African drug discovery? A: Yes, it discusses the historical context of drug discovery in South Africa. The book examines the legacies of apartheid and resource extraction.
- Q: Is there a focus on any specific diseases in 'Synthesizing Hope'? A: Yes, the book focuses on drug discovery for tuberculosis, HIV, and malaria. These diseases are critical issues in global health.
- Q: What kind of audience would benefit from reading 'Synthesizing Hope'? A: Scholars, students, and professionals in public health, sociology, and pharmaceuticals would benefit from this book. It offers diverse perspectives on drug discovery.
- Q: What insights does 'Synthesizing Hope' provide about pharmaceutical manufacturing? A: The book provides insights into the processes and infrastructures of pharmaceutical manufacturing in South Africa. It emphasizes the materiality and context of drug production.
- Q: How does 'Synthesizing Hope' contribute to discussions on postcolonial science? A: It highlights the constraints and promises of postcolonial science. The book sheds light on who makes knowledge and where it is produced.